The consumer reported conflicting results with the binaxnow covid-19 antigen self test performed on (b)(6) 2022 on a nasal swab.The consumers tested twice.The first result was negative and the second result appeared to be positive.No additional patient information, including treatment and outcome, was provided.
|
Testing was performed at abbott diagnostics (b)(6) on retained kit lot 185246 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160/ lot 185246, test base part number 195-430h/ lot 181589.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 185246 showed that the complaint rate is (b)(4).A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 185246 showed that the complaint rate is (b)(4).Abbott diagnostics (b)(4) was unable to determine the exact root cause of the reported issue; however, it could possibly be related to issues including the self-test user performance, interpretation of the result, or the specific patient sample.
|